Skip to content
HowShorted

Fulgent Genetics, Inc. short interest in 2024

In 2024, Fulgent Genetics, Inc.'s disclosed short interest ran from 1.72% of shares outstanding on 12 Jan 2024 to 3.17% on 31 Dec 2024, a change of +1.45 percentage points. The year's high was 3.17% on 31 Dec 2024 and its low 1.59% on 31 Jan 2024, averaging 2.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.13 days on 30 Aug 2024. Full history: Fulgent Genetics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Fulgent Genetics, Inc. in 2024

2024 in figures

Start of year
1.72% (12 Jan 2024)
End of year
3.17% (31 Dec 2024)
Change
+1.45 pp
High
3.17% (31 Dec 2024)
Low
1.59% (31 Jan 2024)
Average
2.25%
Highest days to cover
7.13 (30 Aug 2024)
SEC filings marked
8

Every report in 2024

Fulgent Genetics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.72%4.14
31 Jan 20241.59%3.08
15 Feb 20241.75%2.80
29 Feb 20241.68%1.3110-K filed, results (8-K)
15 Mar 20242.06%2.27
28 Mar 20242.04%3.70
15 Apr 20242.11%4.10
30 Apr 20242.30%3.89
15 May 20242.35%3.8910-Q filed, results (8-K)
31 May 20242.41%5.75
14 Jun 20242.62%6.30
28 Jun 20242.61%3.42
15 Jul 20242.62%5.51
31 Jul 20242.29%2.86
15 Aug 20242.31%3.1710-Q filed, results (8-K)
30 Aug 20242.42%7.13
13 Sep 20242.39%6.13
30 Sep 20242.11%4.22
15 Oct 20242.23%5.43
31 Oct 20242.13%4.16
15 Nov 20241.89%2.0010-Q filed, results (8-K)
29 Nov 20242.45%3.04
13 Dec 20242.69%2.84
31 Dec 20243.17%3.21

See also: Fulgent Genetics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.